Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Forssell-Aronsson

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
EJNMMI Research|June 12, 2012
Microdosimetric analysis of 211At in thyroid models for man, rat and mouseAnders Josefsson, Eva Forssell-Aronsson
Theoretical Biology & Medical Modelling|June 3, 2014
Analysis of inter-patient variations in tumour growth rateEsmaeil Mehrara, Eva Forssell-Aronsson
EJNMMI Research|July 10, 2014
Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle modelsAnders Josefsson, Eva Forssell-Aronsson
Cancers|January 11, 2022
Hyperfractionated Treatment with <sup>177</sup>Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor ModelMikael Elvborn, Emman Shubbar, Eva Forssell-Aronsson
Physics in Medicine and Biology|July 29, 2008
Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapyHelena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Translation of dosimetric results of preclinical radionuclide therapy to clinical situations: influence of photon irradiationHelena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Medical Physics|October 19, 2004
Modelling of metastatic cure after radionuclide therapy: influence of tumor distribution, cross-irradiation, and variable activity concentrationPeter Bernhardt, Hakan Ahlman, Eva Forssell-Aronsson
Medical Physics|January 10, 2004
Model of metastatic growth valuable for radionuclide therapyPeter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Acta Oncologica (Stockholm, Sweden)|December 4, 2003
Radiation therapy through activation of stable nuclidesJörgen Carlsson, Eva Forssell-Aronsson, Bengt Glimelius, et al.
Nuclear Medicine and Biology|June 27, 2007
Transport of free 211At and 125I- in thyroid epithelial cells: effects of anion channel blocker 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid on apical efflux and cellular retentionUlrika Lindencrona, Eva Forssell-Aronsson, Mikael Nilsson
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
EJNMMI Research|June 12, 2012
Microdosimetric analysis of 211At in thyroid models for man, rat and mouseAnders Josefsson, Eva Forssell-Aronsson
Theoretical Biology & Medical Modelling|June 3, 2014
Analysis of inter-patient variations in tumour growth rateEsmaeil Mehrara, Eva Forssell-Aronsson
EJNMMI Research|July 10, 2014
Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle modelsAnders Josefsson, Eva Forssell-Aronsson
Cancers|January 11, 2022
Hyperfractionated Treatment with <sup>177</sup>Lu-Octreotate Increases Tumor Response in Human Small-Intestine Neuroendocrine GOT1 Tumor ModelMikael Elvborn, Emman Shubbar, Eva Forssell-Aronsson
Physics in Medicine and Biology|July 29, 2008
Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapyHelena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
Translation of dosimetric results of preclinical radionuclide therapy to clinical situations: influence of photon irradiationHelena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Medical Physics|October 19, 2004
Modelling of metastatic cure after radionuclide therapy: influence of tumor distribution, cross-irradiation, and variable activity concentrationPeter Bernhardt, Hakan Ahlman, Eva Forssell-Aronsson
Medical Physics|January 10, 2004
Model of metastatic growth valuable for radionuclide therapyPeter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Acta Oncologica (Stockholm, Sweden)|December 4, 2003
Radiation therapy through activation of stable nuclidesJörgen Carlsson, Eva Forssell-Aronsson, Bengt Glimelius, et al.
Nuclear Medicine and Biology|June 27, 2007
Transport of free 211At and 125I- in thyroid epithelial cells: effects of anion channel blocker 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid on apical efflux and cellular retentionUlrika Lindencrona, Eva Forssell-Aronsson, Mikael Nilsson
Pageof 14